Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany proclaims "best ever" mammo screening

This article was originally published in Clinica

Executive Summary

Never before has Germany had such a high-quality and reliable breast screening programme for early cancer detection." So said Andreas Kohler, head of the association of statutory sickness funds (KBV), at a conference this week in Berlin. Sharing the podium was health minister Ulla Schmidt, who said that more than 1.4 million women in Germany have so far made use of the reimbursed breast cancer diagnosis facility that allows women aged 50-69 to be screened every two years. The aim of the programme is to offer early, appropriate and targeted therapy to the 57,000 women in Germany who contract breast cancer every year, and thereby cut mortality rates. Some 17,500 women die from the disease every year in Germany. The programme, which covers 10 million women, offers dual checking by specialists, and subjects the mammography equipment to safety checks daily. The programme costs the sickness funds euro250-300m ($380-450m) per year, but is seen by minister Schmidt as money well spent.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046693

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel